April 29, 2025 10:20 AM EDT
News Briefing

Ab­b­Vie’s Rin­voq is ap­proved in gi­ant cell ar­teri­tis; Rel­ma­da shares blad­der can­cer da­ta

ENDPOINTS

Plus, news about the No­vo Nordisk Foun­da­tion and Tonix:

Ab­b­Vie’s Rin­voq gets la­bel ex­pan­sion: The block­buster JAK in­hibitor won ap­proval in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA de­lays PDU­FA date for small biotech, rais­ing ques­tions about im­pact of agency cuts

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

With a new CEO, oligonu­cleotide biotech Crey­on forges Eli Lil­ly part­ner­ship

Oc­ta­gon Ther­a­peu­tics shuts down af­ter 'un­re­solved bi­ol­o­gy ques­tion­s'

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times